Market Research Logo

TearLab Corp (TEAR) - Product Pipeline Analysis, 2018 Update

Summary

TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. The company conducts it research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. The company sells its products directly in the US, Canada and the UK and through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company TearLab Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


TearLab Corp Company Overview
TearLab Corp Company Snapshot
TearLab Corp Pipeline Products and Ongoing Clinical Trials Overview
TearLab Corp – Pipeline Analysis Overview
Business Description
TearLab Corp - Key Facts
TearLab Corp - Major Products and Services
TearLab Corp Pipeline Products by Development Stage
TearLab Corp Pipeline Products Overview
Multiplex Test Card
Multiplex Test Card Product Overview
Next Generation TearLab Osmolarity System
Next Generation TearLab Osmolarity System Product Overview
TearLab Discovery System
TearLab Discovery System Product Overview
TearLab Corp - Key Competitors
TearLab Corp - Key Employees
TearLab Corp - Key Employee Biographies
TearLab Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
TearLab Corp, Recent Developments
May 10, 2018: TearLab Announces First Quarter 2018 Financial Results
Apr 11, 2018: TearLab Provides Update on 510(k) Filing for U.S. FDA Clearance of TearLab Discovery Platform
Mar 16, 2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange
Mar 02, 2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 01, 2018: European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects
Feb 28, 2018: TearLab Osmolarity System Launches in Brazil
Feb 16, 2018: Spanish center Santiago de Compostela joins the largest ever prospective study into familial risk of developing pancreatic cancer
Feb 14, 2018: TearLab Provides Update on i-Pen Osmolarity System
Feb 14, 2018: TearLab Provides Update on TearLab Discovery Platform
Feb 13, 2018: Radiometer helps enhance patient outcomes at the University of Leicester Hospitals NHS Trust
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
TearLab Corp Pipeline Products and Ongoing Clinical Trials Overview
TearLab Corp Pipeline Products by Equipment Type
TearLab Corp Pipeline Products by Indication
TearLab Corp, Key Facts
TearLab Corp, Major Products and Services
TearLab Corp Number of Pipeline Products by Development Stage
TearLab Corp Pipeline Products Summary by Development Stage
Multiplex Test Card - Product Status
Multiplex Test Card - Product Description
Next Generation TearLab Osmolarity System - Product Status
Next Generation TearLab Osmolarity System - Product Description
TearLab Discovery System - Product Status
TearLab Discovery System - Product Description
TearLab Corp, Key Employees
TearLab Corp, Key Employee Biographies
TearLab Corp, Subsidiaries
Glossary
List of Figures
TearLab Corp Pipeline Products by Equipment Type
TearLab Corp Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report